2,3-dihydro-1,4-benzoxazin-4-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;2,3-dihydroindol-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;1,3-dihydroisoindol-2-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;3,4-dihydro-2H-1,5-naphthyridin-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;3,4-dihydro-2H-1,6-naphthyridin-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;4-[3-(2,2-dimethylpropyl)benzoyl]-1-methylpiperazin-2-one;4-[3-(2,2-dimethylpropyl)benzoyl]piperazin-2-one;[3-(2,2-dimethylpropyl)phenyl]-(6-methyl-3,4-dihydro-2H-quinolin-1-yl)methanone

C155H190N12O11 — CID 160884304

IUPAC2,3-dihydro-1,4-benzoxazin-4-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;2,3-dihydroindol-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;1,3-dihydroisoindol-2-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;3,4-dihydro-2H-1,5-naphthyridin-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;3,4-dihydro-2H-1,6-naphthyridin-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;4-[3-(2,2-dimethylpropyl)benzoyl]-1-methylpiperazin-2-one;4-[3-(2,2-dimethylpropyl)benzoyl]piperazin-2-one;[3-(2,2-dimethylpropyl)phenyl]-(6-methyl-3,4-dihydro-2H-quinolin-1-yl)methanone
SMILESCC(C)(C)Cc1cccc(C(=O)N2CCCc3cnccc32)c1.CC(C)(C)Cc1cccc(C(=O)N2CCCc3ncccc32)c1.CC(C)(C)Cc1cccc(C(=O)N2CCNC(=O)C2)c1.CC(C)(C)Cc1cccc(C(=O)N2CCOc3ccccc32)c1.CC(C)(C)Cc1cccc(C(=O)N2CCc3ccccc32)c1.CC(C)(C)Cc1cccc(C(=O)N2Cc3ccccc3C2)c1.CN1CCN(C(=O)c2cccc(CC(C)(C)C)c2)CC1=O.Cc1ccc2c(c1)CCCN2C(=O)c1cccc(CC(C)(C)C)c1
InChIInChI=1S/C22H27NO.2C20H24N2O.C20H23NO2.2C20H23NO.C17H24N2O2.C16H22N2O2/c1-16-10-11-20-18(13-16)9-6-12-23(20)21(24)19-8-5-7-17(14-19)15-22(2,3)4;1-20(2,3)14-15-7-4-8-16(13-15)19(23)22-12-6-9-17-18(22)10-5-11-21-17;1-20(2,3)13-15-6-4-7-16(12-15)19(23)22-11-5-8-17-14-21-10-9-18(17)22;1-20(2,3)14-15-7-6-8-16(13-15)19(22)21-11-12-23-18-10-5-4-9-17(18)21;1-20(2,3)14-15-7-6-9-17(13-15)19(22)21-12-11-16-8-4-5-10-18(16)21;1-20(2,3)12-15-7-6-10-16(11-15)19(22)21-13-17-8-4-5-9-18(17)14-21;1-17(2,3)11-13-6-5-7-14(10-13)16(21)19-9-8-18(4)15(20)12-19;1-16(2,3)10-12-5-4-6-13(9-12)15(20)18-8-7-17-14(19)11-18/h5,7-8,10-11,13-14H,6,9,12,15H2,1-4H3;4-5,7-8,10-11,13H,6,9,12,14H2,1-3H3;4,6-7,9-10,12,14H,5,8,11,13H2,1-3H3;4-10,13H,11-12,14H2,1-3H3;4-10,13H,11-12,14H2,1-3H3;4-11H,12-14H2,1-3H3;5-7,10H,8-9,11-12H2,1-4H3;4-6,9H,7-8,10-11H2,1-3H3,(H,17,19)
InChIKeySNKWXBIYODOFQZ-UHFFFAOYSA-N
MW2397.30 g/mol
LogP30.96
Rot. Bonds16

About 2,3-dihydro-1,4-benzoxazin-4-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;2,3-dihydroindol-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;1,3-dihydroisoindol-2-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;3,4-dihydro-2H-1,5-naphthyridin-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;3,4-dihydro-2H-1,6-naphthyridin-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;4-[3-(2,2-dimethylpropyl)benzoyl]-1-methylpiperazin-2-one;4-[3-(2,2-dimethylpropyl)benzoyl]piperazin-2-one;[3-(2,2-dimethylpropyl)phenyl]-(6-methyl-3,4-dihydro-2H-quinolin-1-yl)methanone

2,3-dihydro-1,4-benzoxazin-4-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;2,3-dihydroindol-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;1,3-dihydroisoindol-2-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;3,4-dihydro-2H-1,5-naphthyridin-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;3,4-dihydro-2H-1,6-naphthyridin-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;4-[3-(2,2-dimethylpropyl)benzoyl]-1-methylpiperazin-2-one;4-[3-(2,2-dimethylpropyl)benzoyl]piperazin-2-one;[3-(2,2-dimethylpropyl)phenyl]-(6-methyl-3,4-dihydro-2H-quinolin-1-yl)methanone (PubChem CID 160884304) has the molecular formula C155H190N12O11 and a molecular weight of 2397.30 g/mol. Its IUPAC name is 2,3-dihydro-1,4-benzoxazin-4-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;2,3-dihydroindol-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;1,3-dihydroisoindol-2-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;3,4-dihydro-2H-1,5-naphthyridin-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;3,4-dihydro-2H-1,6-naphthyridin-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;4-[3-(2,2-dimethylpropyl)benzoyl]-1-methylpiperazin-2-one;4-[3-(2,2-dimethylpropyl)benzoyl]piperazin-2-one;[3-(2,2-dimethylpropyl)phenyl]-(6-methyl-3,4-dihydro-2H-quinolin-1-yl)methanone.

Molecular Properties

Compound Name2,3-dihydro-1,4-benzoxazin-4-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;2,3-dihydroindol-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;1,3-dihydroisoindol-2-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;3,4-dihydro-2H-1,5-naphthyridin-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;3,4-dihydro-2H-1,6-naphthyridin-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;4-[3-(2,2-dimethylpropyl)benzoyl]-1-methylpiperazin-2-one;4-[3-(2,2-dimethylpropyl)benzoyl]piperazin-2-one;[3-(2,2-dimethylpropyl)phenyl]-(6-methyl-3,4-dihydro-2H-quinolin-1-yl)methanone
PubChem CID160884304
Molecular FormulaC155H190N12O11
Molecular Weight2397.30 g/mol
Exact Mass2395.47
IUPAC Name2,3-dihydro-1,4-benzoxazin-4-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;2,3-dihydroindol-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;1,3-dihydroisoindol-2-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;3,4-dihydro-2H-1,5-naphthyridin-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;3,4-dihydro-2H-1,6-naphthyridin-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;4-[3-(2,2-dimethylpropyl)benzoyl]-1-methylpiperazin-2-one;4-[3-(2,2-dimethylpropyl)benzoyl]piperazin-2-one;[3-(2,2-dimethylpropyl)phenyl]-(6-methyl-3,4-dihydro-2H-quinolin-1-yl)methanone
SMILESCC(C)(C)Cc1cccc(C(=O)N2CCCc3cnccc32)c1.CC(C)(C)Cc1cccc(C(=O)N2CCCc3ncccc32)c1.CC(C)(C)Cc1cccc(C(=O)N2CCNC(=O)C2)c1.CC(C)(C)Cc1cccc(C(=O)N2CCOc3ccccc32)c1.CC(C)(C)Cc1cccc(C(=O)N2CCc3ccccc32)c1.CC(C)(C)Cc1cccc(C(=O)N2Cc3ccccc3C2)c1.CN1CCN(C(=O)c2cccc(CC(C)(C)C)c2)CC1=O.Cc1ccc2c(c1)CCCN2C(=O)c1cccc(CC(C)(C)C)c1
InChIInChI=1S/C22H27NO.2C20H24N2O.C20H23NO2.2C20H23NO.C17H24N2O2.C16H22N2O2/c1-16-10-11-20-18(13-16)9-6-12-23(20)21(24)19-8-5-7-17(14-19)15-22(2,3)4;1-20(2,3)14-15-7-4-8-16(13-15)19(23)22-12-6-9-17-18(22)10-5-11-21-17;1-20(2,3)13-15-6-4-7-16(12-15)19(23)22-11-5-8-17-14-21-10-9-18(17)22;1-20(2,3)14-15-7-6-8-16(13-15)19(22)21-11-12-23-18-10-5-4-9-17(18)21;1-20(2,3)14-15-7-6-9-17(13-15)19(22)21-12-11-16-8-4-5-10-18(16)21;1-20(2,3)12-15-7-6-10-16(11-15)19(22)21-13-17-8-4-5-9-18(17)14-21;1-17(2,3)11-13-6-5-7-14(10-13)16(21)19-9-8-18(4)15(20)12-19;1-16(2,3)10-12-5-4-6-13(9-12)15(20)18-8-7-17-14(19)11-18/h5,7-8,10-11,13-14H,6,9,12,15H2,1-4H3;4-5,7-8,10-11,13H,6,9,12,14H2,1-3H3;4,6-7,9-10,12,14H,5,8,11,13H2,1-3H3;4-10,13H,11-12,14H2,1-3H3;4-10,13H,11-12,14H2,1-3H3;4-11H,12-14H2,1-3H3;5-7,10H,8-9,11-12H2,1-4H3;4-6,9H,7-8,10-11H2,1-3H3,(H,17,19)
InChIKeySNKWXBIYODOFQZ-UHFFFAOYSA-N
XLogP30.96
TPSA246.90 Ų
H-Bond Donors1
H-Bond Acceptors13
Rotatable Bonds16
Heavy Atoms178
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002397.30
LogP ≤ 530.96
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1013

Analyze 2,3-dihydro-1,4-benzoxazin-4-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;2,3-dihydroindol-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;1,3-dihydroisoindol-2-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;3,4-dihydro-2H-1,5-naphthyridin-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;3,4-dihydro-2H-1,6-naphthyridin-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;4-[3-(2,2-dimethylpropyl)benzoyl]-1-methylpiperazin-2-one;4-[3-(2,2-dimethylpropyl)benzoyl]piperazin-2-one;[3-(2,2-dimethylpropyl)phenyl]-(6-methyl-3,4-dihydro-2H-quinolin-1-yl)methanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-[(E)-2-(4-methoxyphenyl)vinyl]-N-[1-methyl-5-[[1-methyl-5-(2-morpholinoethylcarbamoyl)pyrrol-3-yl]carbamoyl]pyrrol-3-yl]quinoline-6-carboxamide
CID 23730381
1-[2-Ethoxy-4-(4-piperidin-1-ylpiperidin-1-yl)phenyl]-9-(6-methyl-3-pyridinyl)benzo[h][1,6]naphthyridin-2-one;1-[2-ethoxy-4-(4-piperidin-1-ylpiperidin-1-yl)phenyl]-9-quinolin-3-ylbenzo[h][1,6]naphthyridin-2-one;9-[(6-methyl-3-pyridinyl)methyl]-1-[4-piperazin-1-yl-3-(trifluoromethyl)phenyl]benzo[h][1,6]naphthyridin-2-one;9-(6-methyl-3-pyridinyl)-1-[4-(2-oxopyrrolidin-1-yl)phenyl]benzo[h][1,6]naphthyridin-2-one;1-[4-(2-oxopyrrolidin-1-yl)phenyl]-9-quinolin-3-ylbenzo[h][1,6]naphthyridin-2-one
CID 157486332
2-[1-[2-(3-oxo-1,4-benzoxazin-4-yl)ethyl]piperidin-4-yl]-N-(2-pyridin-2-ylethyl)benzamide;2-[1-[2-(3-oxo-1,4-benzoxazin-4-yl)ethyl]piperidin-4-yl]-N-(pyridin-2-ylmethyl)benzamide;2-[1-[2-(3-oxo-1,4-benzoxazin-4-yl)ethyl]piperidin-4-yl]-N-[2-[4-(trifluoromethyl)phenyl]ethyl]benzamide
CID 158261932
1-[4-(4-Acetylphenyl)-3-(trifluoromethyl)phenyl]-9-quinolin-3-ylbenzo[h][1,6]naphthyridin-2-one;4-[4-(2-oxo-9-quinolin-3-ylbenzo[h][1,6]naphthyridin-1-yl)-2-(trifluoromethyl)phenyl]benzamide;1-[4-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-3-(trifluoromethyl)phenyl]-9-quinolin-3-ylbenzo[h][1,6]naphthyridin-2-one;9-quinolin-3-yl-1-[4-(1,2,3,6-tetrahydropyridin-4-yl)-3-(trifluoromethyl)phenyl]benzo[h][1,6]naphthyridin-2-one
CID 160571960
3-[5-[[7-[6-[(3R)-6-amino-2-[(1-fluorocyclopropyl)methyl]-5-methanimidoyl-3-methyl-3,4-dihydro-1H-isoquinolin-1-yl]-3-pyridinyl]-7-azaspiro[3.5]nonan-2-yl]methyl]-13-oxo-9-oxa-2,5,14-triazatetracyclo[8.7.0.02,7.012,16]heptadeca-1(10),11,16-trien-14-yl]piperidine-2,6-dione
CID 170727352
3-[(7S)-5-[[7-[6-[(1S)-5-ethenyl-3-methyl-6-(methylamino)-2-(2,2,2-trifluoroethyl)-3,4-dihydro-1H-isoquinolin-1-yl]-3-pyridinyl]-7-azaspiro[3.5]nonan-2-yl]methyl]-13-oxo-9-oxa-2,5,14-triazatetracyclo[8.7.0.02,7.012,16]heptadeca-1(10),11,16-trien-14-yl]piperidine-2,6-dione
CID 170728044
2-[5-[[7-[6-[6-amino-2-[(1-fluorocyclopropyl)methyl]-5-methanimidoyl-3,4-dihydro-1H-isoquinolin-1-yl]-3-pyridinyl]-7-azaspiro[3.5]nonan-2-yl]methyl]-13-oxo-9-oxa-2,5,14-triazatetracyclo[8.7.0.02,7.012,16]heptadeca-1(10),11,16-trien-14-yl]-N-methyl-5-oxopentanamide
CID 170728080
3-[(7S)-5-[[2-[6-[(1S)-2-(2,2-difluoroethyl)-5-ethenyl-3-methyl-6-(methylamino)-3,4-dihydro-1H-isoquinolin-1-yl]-3-pyridinyl]-2-azaspiro[3.5]nonan-7-yl]methyl]-13-oxo-9-oxa-2,5,14-triazatetracyclo[8.7.0.02,7.012,16]heptadeca-1(10),11,16-trien-14-yl]piperidine-2,6-dione
CID 170728265
(3S)-3-[5-[[7-[6-[(3R)-5-ethenyl-2-[(1-fluorocyclopropyl)methyl]-3-methyl-6-(methylamino)-3,4-dihydro-1H-isoquinolin-1-yl]-3-pyridinyl]-7-azaspiro[3.5]nonan-2-yl]methyl]-13-oxo-9-oxa-2,5,14-triazatetracyclo[8.7.0.02,7.012,16]heptadeca-1(10),11,16-trien-14-yl]piperidine-2,6-dione
CID 170728334
5-[(E)-3-[[2-[3-[(2,4-dimethylquinolin-8-yl)oxymethyl]-N,2,4-trimethylanilino]-2-oxoethyl]amino]-3-oxoprop-1-enyl]-N-pyridin-4-ylpyridine-2-carboxamide
CID 19603446
5-[3-[[2-[3-[(2,4-dimethylquinolin-8-yl)oxymethyl]-N,2,4-trimethylanilino]-2-oxoethyl]amino]-3-oxoprop-1-enyl]-N-pyridin-4-ylpyridine-2-carboxamide
CID 53648667
2-[2-(4-methoxyphenyl)ethenyl]-N-[1-methyl-5-[[1-methyl-5-(2-morpholin-4-ylethylcarbamoyl)pyrrol-3-yl]carbamoyl]pyrrol-3-yl]quinoline-6-carboxamide
CID 67392648

Frequently Asked Questions

What is the IUPAC name of 2,3-dihydro-1,4-benzoxazin-4-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;2,3-dihydroindol-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;1,3-dihydroisoindol-2-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;3,4-dihydro-2H-1,5-naphthyridin-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;3,4-dihydro-2H-1,6-naphthyridin-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;4-[3-(2,2-dimethylpropyl)benzoyl]-1-methylpiperazin-2-one;4-[3-(2,2-dimethylpropyl)benzoyl]piperazin-2-one;[3-(2,2-dimethylpropyl)phenyl]-(6-methyl-3,4-dihydro-2H-quinolin-1-yl)methanone?
The IUPAC name of 2,3-dihydro-1,4-benzoxazin-4-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;2,3-dihydroindol-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;1,3-dihydroisoindol-2-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;3,4-dihydro-2H-1,5-naphthyridin-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;3,4-dihydro-2H-1,6-naphthyridin-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;4-[3-(2,2-dimethylpropyl)benzoyl]-1-methylpiperazin-2-one;4-[3-(2,2-dimethylpropyl)benzoyl]piperazin-2-one;[3-(2,2-dimethylpropyl)phenyl]-(6-methyl-3,4-dihydro-2H-quinolin-1-yl)methanone (CID 160884304) is 2,3-dihydro-1,4-benzoxazin-4-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;2,3-dihydroindol-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;1,3-dihydroisoindol-2-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;3,4-dihydro-2H-1,5-naphthyridin-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;3,4-dihydro-2H-1,6-naphthyridin-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;4-[3-(2,2-dimethylpropyl)benzoyl]-1-methylpiperazin-2-one;4-[3-(2,2-dimethylpropyl)benzoyl]piperazin-2-one;[3-(2,2-dimethylpropyl)phenyl]-(6-methyl-3,4-dihydro-2H-quinolin-1-yl)methanone.
What is the SMILES notation for 2,3-dihydro-1,4-benzoxazin-4-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;2,3-dihydroindol-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;1,3-dihydroisoindol-2-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;3,4-dihydro-2H-1,5-naphthyridin-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;3,4-dihydro-2H-1,6-naphthyridin-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;4-[3-(2,2-dimethylpropyl)benzoyl]-1-methylpiperazin-2-one;4-[3-(2,2-dimethylpropyl)benzoyl]piperazin-2-one;[3-(2,2-dimethylpropyl)phenyl]-(6-methyl-3,4-dihydro-2H-quinolin-1-yl)methanone?
The canonical SMILES for 2,3-dihydro-1,4-benzoxazin-4-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;2,3-dihydroindol-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;1,3-dihydroisoindol-2-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;3,4-dihydro-2H-1,5-naphthyridin-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;3,4-dihydro-2H-1,6-naphthyridin-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;4-[3-(2,2-dimethylpropyl)benzoyl]-1-methylpiperazin-2-one;4-[3-(2,2-dimethylpropyl)benzoyl]piperazin-2-one;[3-(2,2-dimethylpropyl)phenyl]-(6-methyl-3,4-dihydro-2H-quinolin-1-yl)methanone is CC(C)(C)Cc1cccc(C(=O)N2CCCc3cnccc32)c1.CC(C)(C)Cc1cccc(C(=O)N2CCCc3ncccc32)c1.CC(C)(C)Cc1cccc(C(=O)N2CCNC(=O)C2)c1.CC(C)(C)Cc1cccc(C(=O)N2CCOc3ccccc32)c1.CC(C)(C)Cc1cccc(C(=O)N2CCc3ccccc32)c1.CC(C)(C)Cc1cccc(C(=O)N2Cc3ccccc3C2)c1.CN1CCN(C(=O)c2cccc(CC(C)(C)C)c2)CC1=O.Cc1ccc2c(c1)CCCN2C(=O)c1cccc(CC(C)(C)C)c1.
What is the InChIKey of 2,3-dihydro-1,4-benzoxazin-4-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;2,3-dihydroindol-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;1,3-dihydroisoindol-2-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;3,4-dihydro-2H-1,5-naphthyridin-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;3,4-dihydro-2H-1,6-naphthyridin-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;4-[3-(2,2-dimethylpropyl)benzoyl]-1-methylpiperazin-2-one;4-[3-(2,2-dimethylpropyl)benzoyl]piperazin-2-one;[3-(2,2-dimethylpropyl)phenyl]-(6-methyl-3,4-dihydro-2H-quinolin-1-yl)methanone?
The InChIKey is SNKWXBIYODOFQZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H27NO.2C20H24N2O.C20H23NO2.2C20H23NO.C17H24N2O2.C16H22N2O2/c1-16-10-11-20-18(13-16)9-6-12-23(20)21(24)19-8-5-7-17(14-19)15-22(2,3)4;1-20(2,3)14-15-7-4-8-16(13-15)19(23)22-12-6-9-17-18(22)10-5-11-21-17;1-20(2,3)13-15-6-4-7-16(12-15)19(23)22-11-5-8-17-14-21-10-9-18(17)22;1-20(2,3)14-15-7-6-8-16(13-15)19(22)21-11-12-23-18-10-5-4-9-17(18)21;1-20(2,3)14-15-7-6-9-17(13-15)19(22)21-12-11-16-8-4-5-10-18(16)21;1-20(2,3)12-15-7-6-10-16(11-15)19(22)21-13-17-8-4-5-9-18(17)14-21;1-17(2,3)11-13-6-5-7-14(10-13)16(21)19-9-8-18(4)15(20)12-19;1-16(2,3)10-12-5-4-6-13(9-12)15(20)18-8-7-17-14(19)11-18/h5,7-8,10-11,13-14H,6,9,12,15H2,1-4H3;4-5,7-8,10-11,13H,6,9,12,14H2,1-3H3;4,6-7,9-10,12,14H,5,8,11,13H2,1-3H3;4-10,13H,11-12,14H2,1-3H3;4-10,13H,11-12,14H2,1-3H3;4-11H,12-14H2,1-3H3;5-7,10H,8-9,11-12H2,1-4H3;4-6,9H,7-8,10-11H2,1-3H3,(H,17,19).
What are the key properties of 2,3-dihydro-1,4-benzoxazin-4-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;2,3-dihydroindol-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;1,3-dihydroisoindol-2-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;3,4-dihydro-2H-1,5-naphthyridin-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;3,4-dihydro-2H-1,6-naphthyridin-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;4-[3-(2,2-dimethylpropyl)benzoyl]-1-methylpiperazin-2-one;4-[3-(2,2-dimethylpropyl)benzoyl]piperazin-2-one;[3-(2,2-dimethylpropyl)phenyl]-(6-methyl-3,4-dihydro-2H-quinolin-1-yl)methanone?
2,3-dihydro-1,4-benzoxazin-4-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;2,3-dihydroindol-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;1,3-dihydroisoindol-2-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;3,4-dihydro-2H-1,5-naphthyridin-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;3,4-dihydro-2H-1,6-naphthyridin-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;4-[3-(2,2-dimethylpropyl)benzoyl]-1-methylpiperazin-2-one;4-[3-(2,2-dimethylpropyl)benzoyl]piperazin-2-one;[3-(2,2-dimethylpropyl)phenyl]-(6-methyl-3,4-dihydro-2H-quinolin-1-yl)methanone has a molecular weight of 2397.30 g/mol, XLogP of 30.96, 16 rotatable bonds, 1 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for 2,3-dihydro-1,4-benzoxazin-4-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;2,3-dihydroindol-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;1,3-dihydroisoindol-2-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;3,4-dihydro-2H-1,5-naphthyridin-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;3,4-dihydro-2H-1,6-naphthyridin-1-yl-[3-(2,2-dimethylpropyl)phenyl]methanone;4-[3-(2,2-dimethylpropyl)benzoyl]-1-methylpiperazin-2-one;4-[3-(2,2-dimethylpropyl)benzoyl]piperazin-2-one;[3-(2,2-dimethylpropyl)phenyl]-(6-methyl-3,4-dihydro-2H-quinolin-1-yl)methanone is sourced from PubChem (CID 160884304), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).